Prospective Observational Study of a Precision Medicine Approach in Patients With Advanced Cancer

Prospective observational study of a precision medicine approach in patients with advanced cancer. In this registrational study, patients with advanced cancer undergoing extensive molecular sequencing within the precision oncology program of Charité University Medicine, Berlin will be registered and followed to assess the efficacy of the program and assess the clinical relevance and frequency of molecular alterations, individualized therapies and novel molecular analysis tools.

NCT Number	NCT05926284
Lead Sponsor	Charite University, Berlin, Germany
Conditions	Cancer
Enrollment	2,000 participants
Start Date	2016-03-01
Primary Completion	2030-03-01 (estimated)
Study Completion	2031-03-01 (estimated)
Updated on ClinicalTrials.gov	2023-07-03